GRTSQ — Gritstone bio Balance Sheet
0.000.00%
- $0.00m
- -$15.21m
- $16.34m
Annual balance sheet for Gritstone bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 128 | 171 | 202 | 172 | 79.3 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.482 | — | 1.39 | 0.664 | 0.231 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 131 | 175 | 221 | 183 | 87.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 50.3 | 43.4 | 44.5 | 38.8 | 84.1 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 184 | 222 | 278 | 241 | 178 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 19.5 | 27 | 40 | 34.8 | 27.3 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 50 | 54.8 | 62 | 70 | 126 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 134 | 167 | 216 | 171 | 51.9 |
Total Liabilities & Shareholders' Equity | 184 | 222 | 278 | 241 | 178 |
Total Common Shares Outstanding |